CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
TGF-β2 in Chronic Liver Disease (CLD) and Hepatocellular Carcinoma (HCC)
DOI 10.1055/s-0033-1360882
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Dropmann, A Piiper, EA Alonso, S Weber, K Abshagen, M Wieland, S Nittka, K Breitk-Heinlein, M Janicot, F Jaschinski, H Korhonen, S Dooley
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
TGF-β1 is a pro-fibrogenic cytokine in chronic liver diseases (CLD), driving fibrogenesis. Many experimental approaches to tackle fibrogenesis were directed towards TGF-β1 and provided promising results. However, none of these could be translated into clinical trials for patient treatment up to now. In contrast, clinical trials have been conducted that were directed against TGF-β2. Participation of TGF-β2 in mechani…
Zitieren
Zitierempfehlung
A Dropmann, A Piiper, EA Alonso, S Weber, K Abshagen, M Wieland, S Nittka, K Breitk-Heinlein, M Janicot, F Jaschinski, H Korhonen, S Dooley (2014) TGF-β2 in Chronic Liver Disease (CLD) and Hepatocellular Carcinoma (HCC). Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1360882
Mit CareLit weiterarbeiten